Yes, those are examples of two questions that are repeatedly asked and do not have publicly available answers. Either people do not know these answers or, if they do, they have inside information which they cannot disclose or act on.
As this information becomes able to be publicly disclosed, such as non-disclosure agreements being removed, then we can discuss the information that is provided to the market by the company. In the meantime, these questions should be directed to the company, either MNS, IM3NY or C4V (to which the answer will likely be something along the lines of "we can not disclose this information due to the sensitive nature of our relationship with these entities and existing non-disclosure agreements that are in place").
Thank you for understanding my point. I am glad we can clear that up. Do you have any questions about the above or are you now comfortable waiting for the market to be informed of this information when the company is able to do so in the future?
- Forums
- ASX - By Stock
- MNS
- General Discussion Topics
General Discussion Topics, page-3295
-
- There are more pages in this discussion • 5,104 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MNS (ASX) to my watchlist
|
|||||
Last
4.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $50.37M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
MNS (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online